Princeton, New Jersey, July 21, 2014 – Sandoz today announced an agreement with Anacor Pharmaceuticals, Inc. to obtain exclusive rights to commercialize Anacor’s drug KERYDINTM (tavaborole) topical solution, 5% in the US, through its branded dermatolog…
Princeton, New Jersey, July 14, 2014 – Sandoz today announced the US market introduction of tobramycin inhalation solution, USP, an authorized generic version of TOBI®, currently marketed by Novartis Pharmaceuticals Corporation1.Tobramycin inhalation s…
Basel, July 17, 2014 – Commenting on the results, Joseph Jimenez, CEO of Novartis, said: “Novartis delivered solid financial performance with core margin expansion in the second quarter and first half. Pharmaceuticals, in particular, showed improved pr…
Today, Sandoz announced that the European Generic medicines Agency (EGA) has reelected Dr. Joerg Windisch, Chief Science Officer at Sandoz, as chair of its European Biosimilars Group (EBG).Read more
Princeton, New Jersey, July 8, 2014 – Sandoz today announced the US introduction of an authorized generic version of Diovan® (valsartan) tablets for the treatment of high blood pressure (HBP).This launch follows the Sandoz US introduction of an author…
Sandoz, the global leader in biosimilars, recently hosted an event in Paris for key stakeholders to discuss strategic issues impacting biosimilars and help them better understand their vital role in the success of these important therapies in France.Re…
Sandoz makes long-term commitment to support UN initiative on child mortalityCommitment to UN Every Newborn Action Plan involves development and supply of recommended WHO formulation for treating childhood pneumoniaPneumonia is the leading cause of dea…
Sweden is fourth European country to launch Sandoz’s award-winning new inhaler for patients with asthma and COPDSandoz Sweden launches both 50-500 and 50-250 microgram dosage forms, following national marketing authorization earlier this yearAirflusal …
Sandoz Japan launches valsartan, the first authorized generic ARB in Japan. Sandoz also launches authorized generic of Zometa® for i.v. infusion 4mg/5mL and generic version of Preminent® Tablets LDTokyo, June 20, 2014 Sandoz announces today the launch …
GlaxoSmithKline withdraws application for preliminary injunction on German marketing and distribution of Sandoz’s award-winning AirFluSal® Forspiro®GSK application withdrawn shortly before Cologne Court of Appeals was due to rule in the case, restoring…